NEW YORK (dpa-AFX) – The US stock markets started the new stock market week without a clear direction. While the standard values on Wall Street were mostly in the red, the technology stocks on the Nasdaq continued their latest climb. Investors are focusing on the monetary policy comments and decisions of the US Federal Reserve announced for Wednesday. Most analysts believe that the Fed will stick to its extremely loose monetary policy despite the recent sharp rise in inflation.
The Dow Jones Industrial traded on Monday 0.76 percent lower at 34 218.16 points. The S&P 500, which represents the broad market, fell by 0.28 percent to 4235.75 meters. For the technology-heavy selection index Nasdaq 100, however, it went up 0.49 percent to 14 066.81 points. It is thus approaching the previous record high of 14 073 points at the end of April.
A corona vaccine once again hit the headlines on Monday, this time the one that has not yet been approved by Novavax. The biotech company announced that its own active ingredient had shown itself to be highly effective in tests, including against mutations of the virus. According to the information, it should protect 90 percent from all symptoms, and 100 percent from severe courses. However, investors left it relatively cold: Novavax shares recently fell by 0.1 percent.
The share certificates of the popular corona vaccine manufacturers Biontech and Moderna also had to give up. Biontech fell by more than 6 percent, Moderna papers lost 5.7 percent.
In the case of Oatly shares, the first analyst assessments came into focus after the successful IPO. After a rally in the first few days from the $ 17 issue price to $ 28.73 on Friday, many experts are now approaching the oat drink manufacturer with a neutral vote, including renowned houses such as JPMorgan or Morgan Stanley. The papers slumped 8.0 percent due to profit-taking./edh/he
– –
